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pen access Abstract Cardiotoxicity is one of the major side effects of anthracycline antibiotics. Most studies
implicated increased oxidative stress as the major determinant of doxorubicin (DOX) cardiotoxicity.
The aim of the current investigation was to study the possible cardioprotective effect of Stachys
schimperi Vatke (family Lamiaceae) on DOX-induced cardiotoxicity in rats based on biochemical
and histopathological parameters. The phenolic proﬁle of the methanol extract was determined qual-
itatively by HPLC. Isoscutellarein 7-O-[200-O-(60 0 0-acetyl)-b-D-allopyranosyl]-b-D-glucopyranoside
(compound 1) was isolated and identiﬁed from EB fraction as a major constituent for the ﬁrst time
from this Stachys species. The methanolic extract and the combined EtOAc and n-butanol fractions
(EB) as well as compound 1 showed prominent free radical scavenging activity when assessed by the
DPPH method. The methanolic extract showed moderate protection against DOX-induced
alteration in cardiac oxidative stress markers; GSH and MDA, and cardiac serum markers;
CK-MB and LDH activities. Additionally, histopathological study denoted mild protection against
DOX-induced cardiotoxicity.5847211.
m (E. Abdel-Sattar).
Cairo University. Production
aculty of Pharmacy, Cairo
lsevier
under CC BY-NC-ND license.
42 E. Abdel-Sattar et al.It was concluded that Stachys schimperi Vatke methanolic extract protected against DOX-induced
cardiotoxicity, at least in part, by virtue of its antioxidant activity.
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Doxorubicin (DOX) is one of the most effective antitumor anti-
biotics belonging to the class of anthracyclines. However, its use
is limited by a high incidence of cardiotoxicity.1 With the in-
crease of its use, an acute cardiotoxicity has been recognized
as a severe complication of DOX chemotherapy.2 Although
numerous mechanisms have been proposed, most studies sup-
ported that an increase in oxidative stress, along with reductions
in the levels of antioxidants, which play a key role in the path-
ogenesis of DOX-induced cardiomyopathy.3,4 Therefore, the
use of natural or synthetic antioxidants might protect against
the oxidative stress caused by DOX and other cytotoxic drugs.5
Diets rich in fruits and vegetables have been associated with
decreased risks of several chronic diseases, such as coronary
heart disease and some cancers.6–8 These protective effects have
been attributed partly to the various antioxidant compounds,
e.g. vitamins C and E, b-carotene and polyphenolics.9 Lyco-
pene, a carotenoid occurring in tomatoes10 and gingerols in
Zingiber ofﬁcinale11 were found to protect against DOX-
induced nephrotoxicity. The antioxidant properties of ﬂavo-
noids were shown to reduce DOX-toxicity due to their ability
to chelate free radical.12–14 Investigations on the antioxidant
activity of herbs that are used for treating cancer show that
polyphenols are the carriers of these properties.15,16 Phenolic
compounds are known to act as antioxidants not only because
of their ability to donate hydrogen or electrons but also because
they are stable radical intermediates.17 Probably the most
important natural phenolics are ﬂavonoids because of their
broad spectrum of chemical and biological activities including
radical scavenging properties.14 Previous reports on Stachys
species have shown the presence of ﬂavonoids and phenolic
acids,18–22 indicating that these plants could possess antioxidant
activity.22
Genus Stachys is one of the largest genera of the family Lam-
iaceae. Plants of this genus have been used in folk medicine for
centuries to treat genital tumors, sclerosis of the spleen, inﬂam-
matory diseases, cough and ulcers.23 In the course of our inter-
est in DOX-cardioprotection from Saudi plants,13,14 Stachys
schimperi was selected to determine its polyphenols proﬁle,
in vitro and in vivo antioxidant activity, in addition to its possi-
ble cardioprotective activity.
2. Experimental
2.1. General
1H NMR spectra were measured on Bruker DRX-400, instru-
ment (1H NMR, 400 MHz, 13C, 100 MHz) in CD3OD and
chemical shifts were given in ppm relative to TMS as the inter-
nal standard. The spectrophotometric measurements were car-
ried out using a Carry 300 Scan spectrophotometer (Varian,
USA). Standard phenolic acid, ﬂavonoidal aglycones and
glycosides and other chemicals were purchased from Sigma–
Aldrich (St. Louis, MO, USA) or from Carl Roth GmbH(Buchenau, Germany). All solvents used are of analytical
grade or HPLC grade and were purchased from Merck
(Darmstadt, Germany).
2.2. Plant material
The plant was collected from Al-Taif-Al-Baha road in May
2009. A herbarium specimen was deposited at the Herbarium
of the Department of Natural Products and Alternative Med-
icine, Faculty of Pharmacy, King Abdulaziz University
(#SS1095). The collected plant was identiﬁed by the staff
of the Department of Biology, Faculty of Science, King
Abdulaziz University. Aerial parts were air-dried and sub-
jected to grinding, then kept in dark air-tight closed containers
until the extraction step.
2.3. Extraction and isolation
The air-dried powdered materials (700 g) were extracted with
methanol (3 · 1500 ml) at room temperature using Ultra turrax
T25 homogenizer (Janke and Kunkel, IKA Laboratories, Sta-
uten, Germany). The crude extract (120 g) was fractionated
with petroleum ether, chloroform, ethyl acetate and n-butanol,
followed by the determination of their free radical scavenging
activity. The EtOAc and n-butanol showed similar chromato-
graphic patterns and were combined together to give EB frac-
tion. The EB fraction (with highest antioxidant activity) was
subjected to fractionation over Si gel 60 H column (160 g,
4 · 100 cm) using EtOAc–MeOH–H2O (17.5:10.5:1.0) to give
three main fractions (frs A–C). Fraction B (822 mg) was sub-
jected to chromatography on a Sephadex LH-20 column
(3 · 22 cm), using a mixture of MeOH–H2O (1:1) as mobile
phase to afford 10 major fractions (B-1 to B-10). Fr. B-2
(121 mg) was further puriﬁed on a reversed-phase RP-18 Si
gel (1 · 20 cm, ﬂow rate 4 ml/min, 10 ml fraction) using
MeOH–H2O (11:9) as eluent. The eluted fractions were moni-
tored by TLC using the following systems, S1: n-butanol–acetic
acid–water (3:1:1) and S2: EtOAc–MeOH–H2O (17.5:10.5:1.0).
TLC chromatograms were visualized under UV-light and by
spraying with AlCl3, as well as by p-anisaldehyde. Fractions
eluted between 19 and 27 afforded 25 mg of pure compound 1.
2.4. HPLC analysis
HPLC analysis was performed on Hewlett Packard 1100,
equipped with a quaternary pump, and connected to diode-ar-
ray detector (DAD) and managed by a HP 9000 workstation
(Agilent Technologies, Palo Alto, CA, USA). Hibar Pre-
packed column RT (RP-18, 250 · 4.6 mm, 5 lm, Merck,
Darmstadt, Germany) maintained at 26 C was used in HPLC
analysis. The mobile phases are (A) aqueous formic acid solu-
tion (pH 3.2) and (B) acetonitrile. The following multi-step lin-
ear gradient was applied: from 13% to 15%B/A in 10 min, 15%
to 25% B/A in 10 min, isocratic 25% B/A for 5 min; 25% to 60
% B/A in 12 min and a ﬁnal step of 5 min to initial conditions.
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The Diode-detector (UV–VIS) spectra were recorded between
wave length 220 and 500 nm and the chromatograms followed
at 254 nm for isoﬂavonoids, 280 for phenolics, and 330 nm
for ﬂavonoids. All authentic and test samples were injected in
triplicate (20 ll). Identiﬁcation of the major constituents of
the MeOH extract was performed using HPLC-DAD based
on comparison of the retention times and superimposed spectra
with reference samples.
2.5. In vitro antioxidant activity
2.5.1. Reducing power
The reducing power of the methanolic extract was determined
according to the method of Oyaizu.24 The sample solution (50,
100 or 200 lg/ml) in methanol (2.5 ml) was mixed with 2.5 ml
of 200 mM sodium phosphate buffer (pH 6.6) and 2.5 ml of
1% potassium ferricyanide and the mixture was incubated at
50 C for 20 min. Then, 2.5 ml of 10% trichloroacetic acid
were added, and the mixture was centrifuged at 200 g for
10 min. The upper layer (2.5 ml) was mixed with 2.5 ml of
deionized water and 0.5 ml of 0.1% ferric chloride. Finally
the absorbance was measured at 700 nm against a blank.
Ascorbic acid was used as a positive control.
2.5.2. Total antioxidant activity
The total antioxidant activity of the methanolic extract was as-
sessed using the linoleic acid system.25 The sample solution
(100 lg/ml; 0.2 ml) was added to a solution of linoleic acid
(0.13 ml), 99.8% ethanol (10 ml), and 0.2 M phosphate buffer
(pH 7.0, 10 ml). The total volume was adjusted to 25 ml with
distilled water. The reaction mixture was incubated at 40 C,
and the degree of oxidation was measured according to the
thiocyanate method26 by sequentially adding ethanol (10 ml,
75%), ammonium thiocyanate (0.2 ml, 30%), sample solution
(0.2 ml), and ferrous chloride (20 mM in 3.5% HCl) solution
(0.2 ml). After the mixture was stirred for 3 min, the peroxide
value was determined by reading the absorbance at 500 nm,
and the percentage inhibition of linoleic acid peroxidation,
100  [(absorbance increase of sample/absorbance increase of
control) · 100], was calculated to express antioxidant activity.
All tests and analyses were run in triplicate and averaged.
BHA was used as a positive control.
2.5.3. DPPH radical scavenging activity
The free radical scavenging activity of the methanolic extract
of S. schimperi, as well as its fractions (petroleum ether, chlo-
roform and EB fractions) thereof was determined based on the
scavenging activity of the stable 1,1-diphenyl-2-picrylhydrazyl
(DPPH) using the method described by Braca et al.27 An ali-
quot (0.1 ml) of test samples (50, 100 or 200 lg/ml) was mixed
with 3 ml of a 0.004% MeOH solution of DPPH and kept in
the dark for 30 min. The absorbance was determined at
517 nm, and the percentage inhibition activity was calculated
from the following equation:
½ðA0  A1Þ=A0=100;
where A0 is the absorbance of the control, and A1 is the absor-
bance of the extract or standard. The DPPH solution without
sample solution was used as control. All tests were run in trip-
licate. Ascorbic acid was used as positive control.2.6. In vivo studies
2.6.1. Animals and experimental protocol
Male Wister rats, weighing 250–300 g were used in the study in
accordance with the guidelines of the Biochemical and Re-
search Ethical Committee at King Abdulaziz University, Jeddah,
Saudi Arabia. Animals were housed in a well-ventilated,
temperature-controlled room at 22 ± 3 C with 12 h light-
dark cycle. Food consisted of normal rat chow and water
was provided ad libitum. Care was taken to avoid stressful con-
ditions. All experimental procedures were performed between
8 and 10 a.m. Rats were randomly assigned into four groups
(12 rats each). Group I received CMC (0.5%) (1 ml/200 g body
weight/day) orally for 10 consecutive days. Group II received
CMC orally for 10 consecutive days and a single dose of
DOX (15 mg/kg, i.p.) (EBWE Pharma, A-4866 Unterach, Aus-
tria) on day 7.28 Group III received the methanolic extract of
S. schimperi; suspended in 0.5% CMC (100 mg/kg; orally once
daily for 10 consecutive days). Group IV received the plant ex-
tract combined with DOX in the previously mentioned doses.
The plant extract was administered for 10 consecutive days
and DOX was administered once on day 7. Twenty-four hours
after the plant extract or CMC treatment (day 11), rats were
anesthetized with thiopentone (35 mg/kg; i.p.). Blood samples
were collected by orbital puncture in serum separating tubes.
The blood was centrifuged at 3000g for 15 min to separate
the sera that were kept at 70 C for biochemical analyses.
Abdomen of each rat was opened and hearts were rapidly dis-
sected out, washed in ice-cold isotonic saline and blotted be-
tween two ﬁlter papers. Four hearts from each group were
ﬁxed in 10% formalin for histopathological examination and
the remaining hearts from each group were homogenized in
ice-cold 0.1 M potassium phosphate puffer (pH 7.4) and stored
at 70 C for subsequent analyses.
2.6.2. Cardiac biochemical assay
Cardiac GSH content was determined according to the method
of Adams et al.29 GSSG level was assessed according to the
method of Hissin and Hilf30 and values were expressed as
nmol/mg protein. Lipid peroxidation products were deter-
mined by measuring malondialdehyde (MDA) content in
tissue homogenates according to the method of Mihara and
Uchiyama.31 The MDA content was measured spectrophoto-
metrically at 532 nm. The MDA content was calculated based
on a standard curve using 1,1,3,3-tetraethoxypropane as a stan-
dard. Values are expressed as nmol/g protein.
2.6.3. Serum biochemical assay
Creatine kinase isoenzyme-MB (CK-MB) and lactate dehydro-
genase (LDH) activities were determined according to stan-
dard methods using diagnostic kits from BioSystems S.A.
(Barcelona, Spain). CK-MB activity was assayed by measuring
the rate of NADPH formation at 340 nm.32 LDH activity was
determined by measuring the rate of nicotinamide adenine
dinucleotide reduced form (NADH) formation at 340 nm.33
2.6.4. Histopathological study
Hearts were cut at 0.5 lm, mounted on slides, stained with
hematoxylin and eosin (H&E) and examined under a light
microscope (Olympus BX-50 Olympus Corporation, Tokyo,
Japan).
Table 1 Reducing power of the methanol extract of
S. schimperi.
Absorbance at 700 nm
50 lg/ml 100 lg/ml 200 lg/ml
S. schimperi 0.31 ± 0.01 0.35 ± 0.02 0.61 ± 0.05
Ascorbic acid 1.53 ± 0.06 1.87 ± 0.08 2.87 ± 0.09
Data are the mean ± SEM of six replicates.
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Results are expressed as means ± SEM. Assessment of results
was performed using one-way analysis of variance (ANOVA),
followed by Tukey–Kramer test for multiple comparisons
using Graph Pad In Stat software, Version 4 (Graph Pad Soft-
ware Inc., La Jolla, CA, USA). The statistical signiﬁcance was
accepted at p value below 0.05.
2.8. Isoscutellarein 7-O-[200-O-(60 00-acetyl)-b-D-allopyranosyl -
b-D-glucopyranoside
Yellow amorphous powder, mp 260–262 C (uncorrected);
UV/Vis kmax (MeOH) nm: 276, 306, 327, (NaOMe): 247,
275, 377; (AlCl3): 280, 322, 347; (AlCl3 + HCl): 281, 322,
345 (sh); (NaOAc): 275, 304, 329 (sh), 386; (NaO-
Ac + H3BO3): 276, 305, 327 (sh); 1H NMR (400 MHz,
CD3OD): d7.92 (2H, d, J= 8.40 Hz, H-20, 60), 6.95 (2H, d,
J= 8.4 Hz, H-30, 50), 6.63 (1H, s, H-3), 6.78 (1H, brs, H-6),
4.93 (1H, d, J= 6.9 Hz, H-100), 5.07 (1H, d, J= 6.9 Hz, H-
100 0), 2.1 (3H, s, COCH3), rest of sugar protons 3.5–4.2.
13C
NMR (100 MHz, CD3OD): d 184.64 (C-4),173.11 (CO),
166.83 (C-2), 163.16(C-40), 154.23 (C-5), 152.23 (C-7), 145.46
(C-9), 129.96 (C-20,60), 129.87 (C-8), 123.3 (C-10), 117.18(C-
30,50), 107.86 (C-10), 103.87 (C-3), 104.35 (C-10 00),103.06 (C-
100), 84.14 (C-200), 78.62 (C-500), 77.70 (C-300), 73.54 (C-500 0),
73.23 (C-20 0 0), 72.73 (C-30 00), 70.9 (C-400), 68.62 (C-40 00), 65.15
(C-60 00), 62.42 (C-600), 20.98 (Ac).
3. Results
The present study describes the chemical and biological (car-
dioprotective effect) evaluation of the methanolic extract of
the aerial parts of S. schimperi.
3.1. HPLC analysis
Qualitative HPLC proﬁle of the methanolic extract of S. schim-
peri was performed using HPLC coupled with DAD detector
and monitored at wave lengths 254, 280 and 330 nm. Qualita-
tive HPLC analysis of themajor peaks of themethanolic extract
was based on the comparison of their retention times and super-
imposed spectra with reference standards. The following ﬂavo-
noids were identiﬁed: rutin, kaempferol, isorhamnetin, luteolin,
hypersoid, and isoﬂavonoid daidzein; phenolic acids: (E)-hy-
droxyl cinnamic acid, hydroxy-4-phenylbutanoic acid, syringic
acid, vanillic acid, ferulic acid and p-coumaric acid; in addition
to the isolated isoscutellarein 7-O-[200-O-(600 0-acetyl)-b-D-allo-
pyranosyl-b-D-glucopyranoside ﬂavonoid glycoside from EB
fraction.
3.2. Compound 1
Compound 1 was identiﬁed using spectral analysis (UV, 1D
and 2D NMR). UV analysis in methanol (kmax nm: 276, 306,
327) and after addition of different shift reagents revealed a
ﬂavone skeleton.34 The presence of two anomeric protons
and carbons (1H and 13C NMR) indicated a diglycoside ﬂa-
vone. The sugar moieties were identiﬁed as allose and glucose
based on extensive study of its NMR spectra (2D NMR: H–H
COSY, HSQC, HMBC) and by comparison to the data in lit-
erature.35,36 The presence of an acetyl group was conﬁrmedfrom signals at dH 2.1 (check) and dC 20.98 which attached
to C-6 of the allose moiety (HMBC). The aglycon moiety
was identiﬁed as isoscutellarein based on its NMR data and
by comparison with reported data.35 From the previous data
and by comparison to the reported data, compound 1 was
identiﬁed as isoscutellarein7-O-[200-O-(60 00-acetyl)-b-D-allopyr-
anosyl-b-D-glucopyranoside.35,36
3.3. In vitro antioxidant activity
3.3.1. Reducing power
Table 1 shows the reducing power of methanol extract com-
pared to ascorbic acid based on the conversion of the Fe3+
into Fe2+ in the presence of extract samples using the method
followed by Oyaizu.24 The concentrations 50, 100, and 200 lg/
ml were used in the in vitro evaluation of the reducing capacity.
The reducing power of methanol extracts increases with
increasing concentration of sample. The methanolic extract
showed a moderate reducing power of 0.61 at a concentration
of 200 lg/ml.
3.3.2. Total antioxidant activity
Antioxidant activity of the methanol extract of S. schimperiwas
assessed using the linoleic acid system. The degree of oxidation
was measured according to the thiocyanate method. Butylated
hydroxyanisole (BHA) was used as a reference standard antiox-
idant. The results (Table 2) indicate that the methanolic extract
at concentration of 100 lg/ml exhibited obvious antioxidant
activity (60%) but was not superior to BHA (96%).
3.3.3. DPPH radical scavenging activity
Based on the previous results, the antioxidant activity of the
methanolic extract as well as its fractions and compound 1were
examined by exploring the scavenging activity of the stable 1,1-
diphenyl-2-picrylhydrazyl (DPPH) free radical (Table 3). The
IC50 of all tested samples were determined. The reduction capa-
bility of the extract to DPPH radical is determined by the de-
crease in absorbance at 517 nm induced by antioxidants.
Ascorbic acid is commonly used as a reference standard. All
samples were able to reduce the stable radical DPPH to the yel-
low colored diphenylpicrylhydrazine. Thus, all samples
exhibited observable free radicle scavenging activity in a
dose-related manner (Table 3).
The results of scavenging activity of DPPH free radical
(IC50) of the methanol extract, EB fraction and compound 1
were as follows: 62.1, 10.3 lg/ml and 4.95 ng/ml, respectively.
3.4. In vivo studies
3.4.1. Effects of the methanolic extract of S. schimperi on tissue
and serum cardiac markers
The data in Table 4 show the effect of administration of the
tested extract (100 mg/kg/day) on the oxidant status in cardiac
Table 2 The antioxidant activity of the methanol extract of S.
schimperi.
% Inhibition (100 lg/ml)
S. schimperi 60 ± 0.09
BHA 96 ± 0.12
Data are the mean ± SEM of six replicates; BHA: butylated
hydroxyanisole.
Table 3 DPPH free radical scavenging activity of compound
1, methanol extract and EB fraction.
IC50 lg/ml
Qurecetin MeOH
extract
EB
fraction
Compound 1
(ng/ml)
8.04 ± 0.18 62.1 ± 0.30 10.3 ± 0.13 4.95 ± 0.60
Data are the mean ± SEM of six replicates; EB: combined EtOAc
and n-butanol fractions.
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markers of cardiac injury. The extract exhibited no signiﬁcant
alteration in the assessed parameters as compared to the con-
trol (saline-treated) group. This clearly indicates that methanol
extract of S. schimperi was devoid of any cardiotoxicity under
our experimental conditions.
3.4.2. The effect of methanol extract of S. schimperi on DOX-
induced alterations in cardiac tissue oxidative stress
The data in (Table 5) indicated that the treatment of rats with
DOX resulted in a severe oxidative stress in cardiac tissues as
evidenced by signiﬁcant GSH depletion as well as accumula-
tion of lipid peroxides as marked by MDA. The treatment with
S. schimperi extract signiﬁcantly protected against DOX-in-
duced GSH depletion and MDA elevation.Table 4 Effects of the methanol extract of S. schimperi on tissue a
Cardiac tissue
GSH (lmol/g protein) MDA (nmol/g prote
Control 4.42 ± 0.13 55.3 ± 1.80
S. schimperi 4.23 ± 0.21 54.2 ± 2.20
Data are the mean ± SEM of six rats.
Table 5 The effect of methanol extract of S. schimperi on doxorub
GSH and malondialdehyde (MDA) and serum cardiac markers; CK
Cardiac tissue
GSH (lmol/g protein) MDA (nmol/g p
Control 4.42 ± 0.13 55.3 ± 1.80
DOX 1.93a ± 0.06 154a ± 5.30
DOX+ S. schimperi 2.58a,b ± 0.11 121a,b ± 4.70
Data are the mean ± SEM of six rats.
a p< 0.05 vs. corresponding control group.
b p< 0.05 vs. corresponding DOX group.3.4.3. Activity of cardiac serum markers
Activities of serum CK-MB and LDH (Table 5) were assessed
as markers of cardiac injury. DOX insult resulted in signiﬁcant
elevation of the activities of both CK-MB and LDH as com-
pared to the control group. Treatment with S. schimperi ex-
tract showed minor decreases of the level of both LDH and
CK-MB with insigniﬁcant protection against DOX-induced
cardiac injury.
3.5. Histopathological study
Cardiotoxicity induced by DOX was further assessed using
hematoxylin and eosin stained sections. Hearts from control
group (I) and group received plant methanolic extract only
(groups III) showed regular cell distribution and normal myo-
cardium architecture (Fig. 1a and b).
Histological examination of the rat hearts from DOX-only
treated rats (group II) revealed severe cytoplasmic vascular
degeneration, interstitial edema and ﬁbrotic bands (Fig. 2a).
Administration of the methanolic extract in addition to
DOX showed mild improvement in the altered histopatholo-
gical pattern (Fig. 2b) as compared to the DOX group.
4. Discussion
Typical phytochemical constituents of the genus Stachys were
essential oils,37,38 C9-iridoidal glycosides,39 labdane, neo-clero-
dane,40 diterpenoids, ﬂavonoids,41 phenylpropanoids,42 and
phenylethanoids.43 Some of these constituents were considered
worth investigation for potential protection against DOX car-
diotoxicity. Of special concern were labdane and ﬂavonoids.
Forskolin, a labdane diterpenoid was reported to possess anti-
hypertensive, positive inotropic, platelet aggregation inhibi-
tory, and adenyl atecyclase activating properties.44 It was
shown to improve experimentally-induced heart failure.45
Flavonoids, like quercetin and rutin were shown to protect
against ischemia-reperfusion-induced myocardial infarctionnd serum cardiac markers.
Serum cardiac markers
in) CK-MB (IU/mg protein) LDH (IU/mg protein)
93.0 ± 6.70 122 ± 9.80
93.5 ± 4.07 119 ± 5.08
icin (DOX)-induced alterations in cardiac tissue oxidative stress;
-MB and LDH activities.
Serum Cardiac markers
rotein) CK-MB (IU/mg protein) LDH (IU/mg protein)
93.0 ± 6.70 122 ± 9.80
189.1a ± 10.0 211a ± 10.30
155.5a ± 7.00 182.4a ± 7.70
Figure 1 Effect of methanolic extract of S. schimperi on cardiac histological pattern. Heart sections showing normal histological pattern
(regular cell distribution and normal myocardium architecture) from control group (a) which received carboxymethylcellulose (CMC;
0.5%) for 10 consecutive days and rats which received MeOH extract of S. schimperi, (100 mg/kg/day) suspended in CMC (0.5%) for 10
consecutive days (b) (H&E 125·).
Figure 2 Effect of methanolic extract of S. schimperi on doxorubicin (DOX)-induced alterations in cardiac histopathological pattern.
Plant methanolic extract (100 mg/kg/day for 10 consecutive days) or carboxymethylcellulose (CMC; 0.5%) were administered orally to
rats and DOX (15 mg/kg; i.p.) was administered on the seventh day. (a) heart sections from rats which received CMC and DOX showing
severe cytoplasmic vacular degeneration of the cardiac muscle (V.D), interstitial edema (E) and ﬁbrotic bands, administration of the
methanolic extract in addition to DOX improved the altered histopathological pattern, (b) heart sections from rats which received S.
schimperi extract and DOX showing focal vacular degeneration of the cardiac muscle (V.D) and mild interstitial edema (E), a marginal
inﬂuence (H&E 125·).
46 E. Abdel-Sattar et al.in both normal and type 1 diabetic rats.46 The current results
indicated that Stachys schimperi methanolic extract possesses
a moderate radical scavenging and antioxidant activity with
a modest activity against DOX cardiotoxicity as indicated by
the biochemical markers. However, histopathological exami-
nation indicated minor improvement. The limited cardiopro-
tective effects of the extract can be explained on the ground
basis of the schedule of dosing or the need of higher doses.
Examining individual constituents or different extract frac-
tions and/or modifying the dosing regimen may disclose better
protection against DOX-induced cardiotoxicity. Meanwhile,
mechanisms other than antioxidation are worth considering.
5. Conclusion
In this study, although the DPPH radical-scavenging ability of
the petroleum ether and chloroform extracts of S. schimperi
was insigniﬁcant, it was evident that the methanolic and EB
fractions did show strong, signiﬁcant proton-donating ability
and could serve as free radical-scavenging. Therefore, we stud-
ied S. schimperi for possible protection against cardiotoxicity
induced by DOX. Although the results are not satisfactory,further study will be required by modifying the dose and inves-
tigating the cardioprotective effect of the polar n-butanol
fraction.Acknowledgements
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